C07J 1/0085
The substituent in position 17 alfa being a saturated hydrocarbon group
Official title: {the substituent in position 17 alfa being a saturated hydrocarbon group}
C07J1/0085 (The substituent in position 17 alfa being a saturated hydrocarbon group) appears on 27 US grants and 15 published applications in this corpus.
Search patents in C07J- Granted patents
- 27
- Published applications
- 15
- Assignees
- 15
- Inventors
- 74
- Latest grant
- 16 Jun 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1980 | 1 | 0 |
| 1981 | 1 | 0 |
| 1982 | 0 | 0 |
| 1983 | 0 | 0 |
| 1984 | 1 | 0 |
| 1985 | 1 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 2 | 0 |
| 1996 | 0 | 0 |
| 1997 | 1 | 0 |
| 1998 | 6 | 0 |
| 1999 | 0 | 0 |
| 2000 | 2 | 0 |
| 2001 | 0 | 0 |
| 2002 | 1 | 1 |
| 2003 | 0 | 1 |
| 2004 | 0 | 3 |
| 2005 | 0 | 1 |
| 2006 | 1 | 0 |
| 2007 | 2 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 0 | 2 |
| 2011 | 0 | 0 |
| 2012 | 0 | 1 |
| 2013 | 1 | 0 |
| 2014 | 0 | 0 |
| 2015 | 1 | 0 |
| 2016 | 0 | 0 |
| 2017 | 0 | 1 |
| 2018 | 0 | 0 |
| 2019 | 0 | 2 |
| 2020 | 1 | 0 |
| 2021 | 1 | 2 |
| 2022 | 1 | 0 |
| 2023 | 1 | 1 |
| 2024 | 0 | 0 |
| 2025 | 1 | 0 |
| 2026 | 1 | 0 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- C17, C20, and C21 substituted neuroactive steroids and their methods of use16 Jun 2026US 12,655,175 B2Sage Therapeutics, Inc.
- Intermediates for the preparation of 11-methylene steroids18 Feb 2025US 12,227,537 B2Crystal Pharma, S.A.U.
- Hydroxysteroid compounds, their intermediates, process of preparation, composition and uses thereof3 Jan 2023US 11,542,298 B2Epirium Bio Inc.
- C17, C20, and C21 substituted neuroactive steroids and their methods of use26 Jul 2022US 11,396,525 B2Sage Therapeutics, Inc.
- Process and new intermediates for the preparation of 11-methylene steroids15 Jun 2021US 11,034,716 B2Crystal Pharma, S.A.U.
- C17, c20, and c21 substituted neuroactive steroids and their methods of use13 Apr 2023US 2023/0116347 A1Sage Therapeutics, Inc.
- Intermediates for the preparation of 11-methylene steroids2 Sep 2021US 2021/0269474 A1Crystal Pharma, S.A.U.
- Hydroxysteroid compounds, their intermediates, process of preparation, composition and uses thereof28 Jan 2021US 2021/0024572 A1Epirium Bio Inc.
- C17, c20, and c21 substituted neuroactive steroids and their methods of use15 Aug 2019US 2019/0248831 A1Sage Therapeutics, Inc.
- Process and new intermediates for the preparation of 11-methylene steroids28 Mar 2019US 2019/0092807 A1Crystal Pharma, S.A.U.
Most cited
By later US patents
- Anti-estrogenic compounds and compositions119US 5,395,842 AEndorecherche, Inc. · 1995
- Sex steroid activity inhibitors28US 5,840,735 AEndorecherche, Inc. · 1998
- Benzopyran-containing compounds and method for their use25US 6,060,503 AEndorecherche, Inc. · 2000
- 11.beta.-Substituted-.DELTA..sup.4,9 -estradienes23US 4,233,296 ARoussel Uclaf · 1980
- 11.beta.-aryl-gona-4,9-dien-3-ones19US 5,407,928 ASchering Corporation · 1995